NUCLEAR-CYTOPLASMIC TRANSPORT IS A THERAPEUTIC TARGET IN MYELOFIBROSIS

PURPOSE: Myelofibrosis (MF) is a hematopoietic stem cell neoplasm characterized by bone marrow reticulin fibrosis, extramedullary hematopoiesis, and frequent transformation to acute myeloid leukemia. Constitutive activation of JAK/STAT signaling through mutations in JAK2, CALR, or MPL is central to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Yan, Dongqing, Pomicter, Anthony D., Tantravahi, Srinivas K., Mason, Clinton C., Senina, Anna V., Ahmann, Jonathan M., Wang, Qiang, Than, Hein, Patel, Ami B., Heaton, William L., Eiring, Anna M., Clair, Phillip M., Gantz, Kevin C., Redwine, Hannah M., Swierczek, Sabina I., Halverson, Brayden J., Baloglu, Erkan, Shacham, Sharon, Khorashad, Jamshid S., Kelley, Todd W., Salama, Mohamed E., Miles, Rodney R., Boucher, Kenneth M., Prchal, Josef T., O'Hare, Thomas, Deininger, Michael W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6445677/
https://ncbi.nlm.nih.gov/pubmed/30563936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-0959
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados